INSO BIOSCIENCES INC
Flagstaff, AZ · Founded 2018 · CIK 0001906426 · Medtech · Private
Platform technologies for biological sample preparation
inso.bio →- Grants
- $676K
- 3 awards
- Sector median: 1
- Raised
- $2.5M
- 2 Form D · Apr 2026
- 5 months since last filing
- Contracts
- $400K
- 1 award · Health and Human S
- #402 of 4531 in medtech
- Patents
- 13
- 0 granted · 13 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201820192020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: Microfluidic Technology for Single Cell Multi-Omic Sample Preparation | $250,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Facile Method for Enhanced Pathogen Detection | $250,894 | |
| Private capital raised | Form D · SEC | $1,775,000 | |
| Federal contract | Department of Health and Human Services · SBIR Topic 439 - Advanced Sample Processing Platforms For Downstream Single-cell Multi-omic Analysis | $399,674 | |
| Federal grant | Department of Agriculture · **awards Issued Prior To January 20, 2025, Were Funded Under Previous Administrations And May Not Reflect The Priorities And Policies Of The Current Administration.** Advancements In Plant Genomics Have Improved Plant Breeding Efforts, But Genomic Sample Preparation For The Newest Sequencing Technologies (long-read Sequencing)remains A Key Bottleneck. Preparation Of Plant Genomes Into High-molecular Weight (hmw)dna Is More Challenging Than Both Mammalian Sample Preparation And Short-read Sample | $174,709 | |
| Private capital raised | Form D · SEC | $750,000 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 399 | QUANTITATIVE IMAGING SYSTEMS LLC | $400K | — |
| 400 | ACOUSTIIC, INC. | $400K | — |
| 401 | EISANA CORP | $400K | $125K |
| 402 | INSO BIOSCIENCES INC | $400K | $2.5M |
| 403 | VOXIMETRY INC | $397K | $4.6M |
| 404 | Opko Health, Inc. | $387K | $206M |
| 405 | DXRAY, INC. | $378K | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Adam BisogniDirector
- Harvey TianDirector · Executive Officer
Patents
- Devices, Methods, And Systems For Enriching Cellular Samples By Physical Propertiesapplication
- DEVICES AND METHODS FOR mtDNA EXTRACTIONapplication
- Devices, Methods, And Systems For Extracting Genomic Dna From Cell Samples With Tunable Size Selectionapplication
- DEVICES AND METHODS FOR mtDNA EXTRACTIONapplication
- DEVICES AND METHODS FOR mtDNA EXTRACTIONapplication
- Devices, Methods, And Systems For Enriching Cellular Samples By Physical Propertiesapplication
- Devices, Methods, And Systems For Extracting Genomic Dna From Cell Samples With Tunable Size Selectionapplication
- Devices, Methods, And Systems For Enriching Cellular Samples By Physical Propertiesapplication
- Devices, Methods, And Systems For Extracting Genomic Dna From Cell Samples With Tunable Size Selectionapplication
- Methods And Apparatus For Extracting Or Separating Nucleic Acids From Biological Samplesapplication
- Devices, Methods, And Systems For Extracting Genomic Dna From Cell Samples With Tunable Size Selectionapplication
- Methods And Apparatus For Extracting Or Separating Nucleic Acids From Biological Samplesapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.